Usual Interstitial Pneumonia (UIP) is the Most Common ILD Pattern in Rheumatoid Arthritis
In rheumatoid arthritis-associated interstitial lung disease (RA-ILD), the usual interstitial pneumonia (UIP) pattern is the predominant histologic and radiologic pattern, occurring more frequently than in other connective tissue disease-associated ILDs. 1
Evidence Supporting UIP as the Predominant Pattern
The most recent and authoritative guidelines consistently identify UIP as the most common pattern in RA-ILD:
The 2025 Portuguese multisociety joint statement explicitly states that "in RA-ILD, UIP seems to be predominant" 1, distinguishing it from other connective tissue diseases where nonspecific interstitial pneumonia (NSIP) is more common
The 2024 ACR/CHEST practical guidance confirms that RA-ILD demonstrates UIP pattern more frequently than other CTD-ILDs 2
Multiple research studies corroborate that the proportion of UIP pattern is higher in RA-ILD than in ILD associated with other connective tissue diseases 3
Clinical Significance of the UIP Pattern
The predominance of UIP in RA-ILD carries critical prognostic implications:
UIP pattern in RA-ILD is associated with poor prognosis 2, similar to idiopathic pulmonary fibrosis (IPF)
RA-ILD patients with histological or radiological UIP patterns have significantly worse outcomes than those with non-UIP patterns 3
The UIP pattern shows progressive fibrotic changes with median survival of 2.6-3.0 years in some cohorts 3
Distinguishing Features on Pathology
When UIP occurs in the context of RA, certain histologic features help distinguish it from idiopathic pulmonary fibrosis:
- Prominent lymphoid follicles with germinal centers 4
- Numerous plasma cells in the interstitial chronic inflammation 4
- These features suggest connective tissue disease-related ILD rather than IPF, even when the underlying pattern is UIP 4
Secondary Pattern: NSIP
While UIP predominates, nonspecific interstitial pneumonia (NSIP) is the second most common pattern in RA-ILD 5, 3, 6, 7. The NSIP pattern in RA-ILD generally carries a better prognosis than UIP and may respond more favorably to immunosuppressive therapy.
Common Pitfall to Avoid
Do not assume all RA-ILD behaves like IPF simply because UIP is the predominant pattern. The presence of autoimmune features, both serologically (high-titer rheumatoid factor, anti-CCP antibodies) and histologically (lymphoid aggregates, plasma cells), indicates that some patients may benefit from immunomodulatory therapy in addition to or instead of purely antifibrotic approaches 4, 8.